Serina Therapeutics Inc. (SER)
NYSE: SER
· Real-Time Price · USD
5.28
-0.22 (-4.00%)
At close: Aug 15, 2025, 3:59 PM
5.20
-1.52%
After-hours: Aug 15, 2025, 07:49 PM EDT
Serina Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.65M | -987K | -5.6M | -6.31M | -13.09M | -20.96M | -14.8M | -14.05M | -11.08M | -11.03M | -10.46M | -9.92M | -9.44M | -9.29M | -8.58M | -8.87M | -9.46M | -9.67M |
Depreciation & Amortization | 145K | 186K | 194K | 171K | 148K | 123K | 131K | 131K | 131K | 132K | 132K | 132K | 131K | 131K | 131K | 675K | 1.01M | 1.35M |
Stock-Based Compensation | 3.93M | 3.5M | 2.6M | 1.61M | 511K | 75.33K | 24.32K | 24.32K | 24.32K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 998K | -1.75M | -1.47M | -2.35M | -2.96M | -46K | -309K | -56K | 341K | 256K | 164K | 107K | -26K | -63K | -240K | -527K | -530K | -666K |
Other Non-Cash Items | -8.27M | -19.02M | -10.85M | -4.34M | 5.65M | 16.11M | 9.88M | 6.89M | 4.32M | 4.47M | 4.16M | 4.13M | 4.16M | 2.97M | 2.08M | 1.74M | 1.1M | 963K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.23M | -3.56M | -3.48M | -3.56M | -4.55M | -98K | -403K | 219K | 398K | 391K | 329K | -121K | -764K | -234K | -884K | -998K | -569K | -1.02M |
Operating Cash Flow | -15.62M | -19.88M | -17.14M | -12.43M | -11.33M | -5.34M | -5.63M | -7.07M | -6.44M | -6.17M | -5.94M | -6.26M | -6.91M | -6.86M | -7.86M | -7.83M | -7.83M | -8.38M |
Capital Expenditures | -8K | -8K | -22K | -87K | -203K | -518.34K | -504.34K | -434.34K | -315.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K | -16K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 466K | 466K | 466K | 466K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -466K | n/a | n/a | n/a | 466K |
Other Investing Acitivies | -46K | n/a | n/a | n/a | n/a | n/a | -10M | -10M | -10M | -10M | n/a | n/a | n/a | n/a | -50K | -50K | -50K | -50K |
Investing Cash Flow | -54K | -8K | -22K | -87K | -203K | -518.34K | -10.5M | -10.43M | -10.32M | -10M | n/a | 250K | 250K | 250K | 666K | 416K | 404K | 400K |
Debt Repayment | 109K | 488K | 2.88M | 2.75M | 2.74M | 4.36M | 13.47M | 13.49M | 13.5M | 11.5M | n/a | n/a | n/a | n/a | 2.25M | 3.24M | 5.22M | 8.03M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 10.49M | 4.92M | 5.26M | 337K | 337K | 337K | n/a | 1.5M | 2.5M | 4.5M | 6M | 5.75M | 6.75M | 6.25M | 4.5M | 3.25M | 1.25M | -250K |
Financial Cash Flow | 15.6M | 15.4M | 13.21M | 8.17M | 8.08M | 4.72M | 13.49M | 15M | 16M | 16M | 6M | 5.75M | 6.75M | 6.25M | 7.25M | 6.99M | 6.96M | 8.27M |
Net Cash Flow | -1.85M | -4.49M | -3.95M | 2.84M | 5.85M | 8.48M | 6.97M | -69K | -441K | -168K | 61K | -265K | 87K | -361K | -225K | -78K | -194K | n/a |
Free Cash Flow | -15.63M | -19.89M | -17.16M | -14.62M | -13.52M | -7.84M | -8.12M | -7.38M | -6.76M | -6.17M | -5.94M | -6.26M | -6.91M | -6.86M | -7.86M | -7.83M | -7.84M | -8.4M |